ANTHONY REES: Open Payments
NPI 1104312206 · WEIRTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,555 in 95 payments from 23 companies in 2025. Trend: 2023 $1,237 · 2024 $1,744 · 2025 $1,555
Food & beverage: $1,555
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $317 |
| Novo Nordisk Inc | 13 | $190 |
| Axsome Therapeutics, Inc. | 9 | $161 |
| Viatris Specialty LLC | 6 | $114 |
| PFIZER INC. | 5 | $82 |
| Amgen Inc. | 5 | $81 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $66 |
| Astellas Pharma US Inc | 4 | $65 |
| Phathom Pharmaceuticals, Inc. | 2 | $52 |
| Daiichi Sankyo Inc. | 2 | $48 |
Products named: VRAYLAR, Auvelity, Ozempic, YUPELRI, QULIPTA, CAPLYTA, Veozah, VOQUEZNA.
Industry payments across WV — which companies pay providers there.
